Document Type : Original Article
Authors
1 Dept. of Oral and Maxillofacial Pathology, School of Dentistry, Shahid Sadoughi University of Medical Sciences. Yazd, Iran.
2 Dept. of Oral and Maxillofacial Pathology, School of Dentistry. Social Determinant of Oral Health Research Center, Shahid Sadoughi University of Medical Sciences. Yazd, Iran.
3 Dept. of Pathology, School of Medicine, Shahid Sadoughi University of Medical Sciences. Yazd, Iran.
Abstract
Background: Progesterone (PR) plays a role in the differentiation and growth of various tissues. One of the most common carcinogenic mechanisms of PR is increasing cell proliferation and inhibiting their apoptosis. There are contradictory results from various studies about the expression level of PR receptors in salivary tumors.
Purpose: Considering the sporadic studies and the contradictory results, this study was conducted to determine the expression level of PR receptor in the most common benign and malignant salivary gland tumors.
Materials and Method: In this descriptive cross-sectional study, 58 paraffinized blocks (36 pleomorphic adenoma samples and 22 mucoepidermoid carcinoma samples) were selected. PR receptor immunohistochemical staining was performed on the samples and the resulting slides were examined under a light microscope with 100x magnification. The gleaned data were analyzed with SPSS25 using descriptive statistics, Fisher’s exact test, and Chi-square test.
Results: Out of 36 pleomorphic adenoma samples, one sample expressed PR receptor moderately and two expressed it weakly. Besides, out of 22 mucoepidermoid carcinoma samples, only one sample expressed PR receptor. The comparison of PR receptor expression between two groups was not statistically significant (p Value=0.719).
Conclusion: Based on the findings of this study, it can be concluded that PR receptor cannot probably play a direct role in carcinogenesis and prognosis of benign and malignant salivary tumors.
Highlights
Najmeh Jafari (Google Scholar)
Farinaz Sabaghzadegan (Google Scholar)
Keywords
- El-Attar RH, Deraz EM. Expression of estrogen receptors (ER) and human epidermal growth factor receptor 2 (HER2) in mucoepidermoid carcinoma: Relationship to its grading. Tanta Dent J. 2014; 11: 194–198.
- Irani S, Dehghan A, Kalvandi Z. Correlation of Clinical and Histopathological Features of Salivary Pleomorphic Adenoma. J Dent. 2023; 24: 404-409.
- Jalili A, Jafari N, Tabatabaei SH. Evaluation of Mast Cell Density in Mucoepidermoid Carcinoma and Pleomorphic Adenoma. J Dent. 2023; 24: 245-249.
- Hua H, Zhang H, Kong Q, Jiang Y. Mechanisms for estrogen receptor expression in human cancer. Exp Hematol Oncol. 2018; 7: 24.
- García-Gómez E, González-Pedrajo B, Camacho-Arroyo I. Role of sex steroid hormones in bacterial-host interactions. BioMed Res Int. 2013; 2013: 928290.
- Contaldo M, Boccellino M, Zannini G, Romano A, Sciarra A, Sacco A, et al. Sex Hormones and Inflammation Role in Oral Cancer Progression: A Molecular and Biological Point of View. J Oncology. 2020; 2020: 9587971.
- Safoura S, Mohamad E, Nosrat-Allah E, Fereshte E. Immunohistochemical expression of progesterone receptors in pleomorphic adenoma and adenoid cystic carcinoma. J Cancer Res Ther. 2011; 7: 23-28.
- Ahn JH, Choi SB, Park JM, Kim JY, Park HS, Kim SI, et al. Level of combined estrogen and progesterone receptor expression determines the eligibility for adjuvant endocrine therapy in breast cancer patients. Cancers (Basel). 2021; 13: 5007.
- Valstar MH, Schaapveld M, van*den*Broek EC, van*Velthuysen MF, de*Ridder M, Schmidt MK, et al. Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands. Cancer Med. 2021; 10: 424-434.
- Aquino G, Collina F, Sabatino R, Cerrone M, Longo F, Ionna F, et al. Sex Hormone Receptors in Benign and Malignant Salivary Gland Tumors: Prognostic and Predictive Role. Int J Mol Sci. 2018; 19: 399.
- Lanari C, Wargon V, Rojas P, Molinolo AA. Antiprogestins in breast cancer treatment: are we ready? Endocr Relat Cancer. 2012; 19: R35-R50.
- Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. American J Clin Patho. 2003; 119: 801-806.
- Barnes L, Rao U, Contis L, Krause J, Schwartz A, Scalamogna P. Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and cerbB-2 protein. Oral Surg Oral Med Oral Patho. 1994; 78: 74-80.
- Pires FR, da*Cruz*Perez DE, de*Almeida OP, Kowalski LP. Estrogen receptor expression in salivary gland mucoepidermoid carcinoma and adenoid cystic carcinoma. Pathol Oncol Res. 2004; 10: 166-168.
- Fan CY, Melhem MF, Hosal AS, Grandis JR, Barnes EL. Expression of androgen receptor, epidermal growth factor receptor, and transforming growth factor alpha in salivary duct carcinoma. Arch Otolaryngol Head Neck Surg. 2001; 127: 1075-1079.
- Gaffney EV, Pinkston JA, Eidson JJ. Estrogen receptors in parotid tumors. Endocrine Res. 1995; 21: 635-643.
- Shick PC, Riordan GP, Foss RD. Estrogen and progesterone receptors in salivary gland adenoid cystic carcinoma. Oral Surg Oral Med Oral Patho Oral Radio Endo. 1995; 80: 440-444.
- Ozono S, Onozuka M, Sato K, Ito Y. Immunohistochemical localization of estradiol, progesterone, and progesterone receptor in human salivary glands and salivary adenoid cystic carcinomas. Cell Struct Funct. 1992; 17: 169-175.
- Kolude B, Adisa A, Adeyemi B, Lawal A. Immunohistochemical expression of oestrogen receptor-α and progesterone receptor in salivary gland tumours. J Oral Pathol Med. 2013; 42: 716-719.
- Tabatabaei S, Jafari N, Tafti M, Hosseini A. Immunohistochemical Study of Estrogen Receptor Expression in Adenoid Cystic Carcinoma and Mucoepidermoid Carcinoma of the Salivary Gland. Avicenna J Dent Res. 2016; 8: 3.
- Albert D, Pandurangan SM, Kulkarni P, Kumar SP, Krishnan M, Francis T. Novel Technique for the Surgical Management of Pleomorphic Adenoma of the Upper Lip. Cureus. 2022; 14: e27214.
- Moghadasi N, Andisheh-Tadbir A, Samiee A, Torabi*Ardekani S, Khademi B, Malekzadeh M, et al. Profile of Serum Heat Shock Protein-27 Level in Patients with Salivary Gland Tumor. J Dent. 2022; 23: 251-256.
- Jeergal PA, Karim*Namazi NA, Patil S, Kochar A, Sohoni R, Bussari SB. Mucoepidermoid carcinoma: A retrospective clinicopathologic study of 25 cases. J Oral Maxillofac Patho (JOMFP). 2021; 25: 490-493.
- Dori S, Trougouboff P, David R, Buchner A. Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin. Oral Oncology. 2000; 36: 450-453.
- Fitzpatrick PJ, Theriault C. Malignant salivary gland tumors. Int J Radiat Oncol Biol Phys. 1986; 12: 1743-1747.
- Ito FA, Ito K, Coletta RD, Vargas PA, Lopes MA. Immunohistochemical study of androgen, estrogen and progesterone receptors in salivary gland tumors. Brazilian Oral Res. 2009; 23: 393-398.
- Barrera JE, Shroyer KR, Said S, Hoernig G, Melrose R, Freedman PD, et al. Estrogen and progesterone receptor and p53 gene expression in adenoid cystic cancer. Head Neck Patho. 2008; 2: 13-18.
- Jeannon JP, Soames JV, Bell H, Wilson JA. Immunohistochemical detection of oestrogen and progesterone receptors in salivary tumours. Clin Otolaryngol Allied Sci. 1999; 24: 52-54.
- Murase R, Sumida T, Ishikawa A, Murase R, McAllister SD, Hamakawa H, et al. Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer. Int J Otolaryng. 2011; 2011: 187623.
)